Stoke Therapeutics, Inc. (0GT.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR

Add to watchlist

10.60

-0.40

(-3.64%)

At close: 08:00AM CEST

Loading interactive chart...

GuruFocus.com
Stoke Therapeutics Inc (STOK) Reports Q1 2024 Financial Results: A Closer Look at Challenges ...
Despite Narrow Miss on EPS, Stoke Therapeutics Advances in Clinical Developments
Simply Wall St.
Stoke Therapeutics First Quarter 2024 Earnings: Beats Expectations
Stoke Therapeutics ( NASDAQ:STOK ) First Quarter 2024 Results Key Financial Results Net loss: US$26.4m (loss widened by...
Zacks
Stoke Therapeutics, Inc. (STOK) Reports Q1 Loss, Tops Revenue Estimates
Stoke Therapeutics (STOK) delivered earnings and revenue surprises of 5% and 26.61%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?